The estimated Net Worth of Paula Cloghessy is at least $82.6 Mille dollars as of 27 October 2023. Ms. Cloghessy owns over 9,418 units of Telesis Bio Inc stock worth over $82,600 and over the last 6 years she sold TBIO stock worth over $0. In addition, she makes $0 as Chief Human Resource Officer at Telesis Bio Inc.
Sign up
Ms. Cloghessy TBIO stock SEC Form 4 insiders trading
Paula has made over 1 trades of the Telesis Bio Inc stock since 2023, according to the Form 4 filled with the SEC. Most recently she exercised 9,418 units of TBIO stock worth $16,011 on 27 October 2023.
The largest trade she's ever made was exercising 9,418 units of Telesis Bio Inc stock on 27 October 2023 worth over $16,011. On average, Paula trades about 1,884 units every 0 days since 2019. As of 27 October 2023 she still owns at least 48,588 units of Telesis Bio Inc stock.
You can see the complete history of Ms. Cloghessy stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Paula Cloghessy biography
Paula Cloghessy serves as Chief Human Resource Officer of the Company. She serves as Translate Bio’s Chief Human Resources Officer and is responsible for leading human resources and organizational development. With over 20 years of experience as a human resources leader driving aggressive organizational strategy, growth and innovation, Paula brings broad-based business experience in biotech and pharmaceutical industries to her role on the Translate team. Paula joined us from Joule Unlimited Technologies, Inc., where she most recently served as vice president, human resources. In this role, she was responsible for leading Joule’s people strategy and talent architecture in a global setting. Prior to Joule, she held senior HR leadership roles at Interleukin Genetics, NUCRYST Pharmaceuticals and the Immune Disease Institute (formerly CBR Institute for Biomedical Research), a Harvard Medical School affiliate. Paula holds a BA in psychology from the University of Massachusetts and professional designations in the field of human resources.
How old is Paula Cloghessy?
Paula Cloghessy is 48, she's been the Chief Human Resource Officer of Telesis Bio Inc since 2018. There are 10 older and 3 younger executives at Telesis Bio Inc. The oldest executive at Telesis Bio Inc is Jean-Francois Formela, 63, who is the Independent Director.
What's Paula Cloghessy's mailing address?
Paula's mailing address filed with the SEC is C/O SERES THERAPEUTICS, INC., 200 SIDNEY STREET, CAMBRIDGE, , 02139.
Insiders trading at Telesis Bio Inc
Over the last 6 years, insiders at Telesis Bio Inc have traded over $269,224,467 worth of Telesis Bio Inc stock and bought 73,047,057 units worth $2,753,701,666 . The most active insiders traders include Sanofi, Plc Gsk e Human Genetic Therapies, In.... On average, Telesis Bio Inc executives and independent directors trade stock every 88 days with the average trade being worth of $7,100,681. The most recent stock trade was executed by Todd Robert Nelson on 4 May 2023, trading 2,575 units of TBIO stock currently worth $7,287.
What does Telesis Bio Inc do?
sgi-dna, a wholly owned subsidiary of synthetic genomics inc., provides genomic solutions to advance scientific discovery. sgi-dna’s ever expanding suite of products, services, reagents, bioinformatics tools and instrumentation enables scientists to discover, design and build novel solutions for basic research, as well as for biomedical and industrial applications. sgi-dna’s genomic services include whole genome sequencing, dna synthesis, library design, bioinformatics, cell engineering, and plasmid dna cloning and purification. sgi-dna’s reagents include a complete suite of gibson assembly® and site directed mutagenesis kits as well as optimized cell lines such as vmax™ a novel, fast growing host system for molecular biology. to further enable synthetic biology workflows, sgi-dna offers the bioxp™ 3200 system. this fully automated genomics workstation allows the creation of double stranded dna fragments, automated cloning, as well as next generation sequencing dna library preparation.
What does Telesis Bio Inc's logo look like?
Complete history of Ms. Cloghessy stock trades at Seres Therapeutics Inc e Telesis Bio Inc
Telesis Bio Inc executives and stock owners
Telesis Bio Inc executives and other stock owners filed with the SEC include:
-
Ronald Renaud,
President, Chief Executive Officer, Director -
Richard Wooster,
Chief Scientific Officer -
John Schroer,
Chief Financial Officer, Treasurer -
Brian Fenton,
Chief Business Officer -
Robert Plenge,
Independent Director -
Robert Meyer,
Independent Director -
George Demetri,
Independent Director -
Daniel Lynch,
Independent Chairman of the Board -
Daniella Beckman,
Independent Director -
Owen Hughes,
Independent Director -
Jean-Francois Formela,
Independent Director -
Ann Barbier,
Chief Medical Officer -
Frank DeRosa,
Chief Technology Officer -
Paula Cloghessy,
Chief Human Resource Officer -
Paul Burgess,
Chief Operating Officer, Chief Legal Officer -
Michael Heartlein,
Founder, Executive Vice President -
Paul M Meister,
Director -
Everett Rand Sutherland,
President -
Brian M. Jr. Gallagher,
Director -
Ventures Fund Llc Mrl,
10% owner -
Venture Fund Viii, L.P.Atla...,
-
Plc Gsk,
10% owner -
Human Genetic Therapies, In...,
-
Fund Iv, L.P.Omega Fund Iv ...,
-
James B Weissman,
-
Michael R. Hodges,
-
Todd Krueger,
-
Steven J Golub,
-
Sarah E. Hlavinka,
-
Daniel Glenn Gibson,
Chief Technology Officer -
Human Genetic Therapies, In...,
-
Group Llc/Ma Baupost Group ...,
-
Brendan Smith,
Chief Financial Officer -
Sanofi,
10% owner -
Ventures Gp, Llc Northpond ...,
-
Fund Iv, Llc Broad Oak,
10% owner -
William Snider,
Director -
William J Kullback,
Chief Financial Officer -
Rob Cutler,
Chief Legal Officer -
Todd Robert Nelson,
Chief Executive Officer -
Eric Eugene Esser,
President & CEO -
Frank Witney,
-
Christine A Tsingos,
-
Annette Tumolo,
-
Gregory J. Herrema,
-
Jami K Nachtsheim,